Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter December 1, 2005

Perinatal outcomes and the use of oral hypoglycemic agents

  • Anna Maria Bertini , Jean Carl Silva , Wladimir Taborda , Felipe Becker , Fernanda Regina Lemos Bebber , Juliana Maria Zucco Viesi , Gabriela Aquim and Thaís Engel Ribeiro

Abstract

Objective: To compare neonatal results from patients with gestational diabetes mellitus (GDM) who were treated with insulin, glyburide and acarbose.

Results: Seventy patients diagnosed with GDM who needed therapy to complement diet and physical activities were included in the study. One group was assigned to insulin therapy (n=27), a second group was assigned to glyburide therapy (n=24) and a third group was assigned to acarbose therapy (n=19). Maternal characteristics were similar in the three groups. Glucose control was not achieved in five (20.8%) of the patients using glyburide and in eight (42.1%) of patients using acarbose. No statistical difference was observed in fasting and post-prandial glucose levels or in average newborn weight in the three groups. The rate of large for gestational age (LGA) fetuses was 3.7, 25 and 10.5% in the groups treated with insulin, glyburide and acarbose, respectively. Neonatal hypoglycemia was observed in eight newborns, six of which from the glyburide group.

Conclusion: We believe that glyburide and acarbose can be promising alternative therapies for the treatment of GDM. Glyburide controlled glucose levels in most patients and it was more efficient than acarbose. Glyburide showed a higher rate of macrosomia and neonatal hypoglycemia as compared to other therapies.

:

Corresponding author: Jean Carl Silva TEGO 0143/1992 Rua Oscar Schneider 205, casa 10 Joinville – SC CEP 89203-050 Brazil Tel.: 55 47 4221356 Fax: 55 47 4226912

References

1 Aberg A, H Rydhstroem, A Frid: Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden. Am J Obstet Gynecol184 (2001) 77Search in Google Scholar

2 Abernethy DR, GJ Arnold, D Azarnoff, et al.: Acarbose. Mosby's Drugs Consult [online] 2003 [citado em 12 Jul 2003];[13 telas]. Disponível em: http://home.mdconsult.comSearch in Google Scholar

3 American Diabetes Association (ADA): Gestational Diabetes mellitus. Diabetes Care 25 (2002) 94Search in Google Scholar

4 Bertini AM: Diabetes mellitus e gravidez. In: Federação brasileira de ginecologia e obstetrícia (ed): Tratado de obstetrícia. Atheneu, São Paulo 2000Search in Google Scholar

5 Bertini AM: Diabetes Mellitus e Gravidez. In: Rezende J. Obstetrícia. 9a ed. Guanabara Koogan, Rio de Janeiro: 2002, p. 413Search in Google Scholar

6 Coetzee EJ, WPU Jackson: Oral hipoglycaemics in the first trimester and fetal outcome. S Afr Med J65 (1984) 635Search in Google Scholar

7 Conselho Nacional de Saúde (CNS): Diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Resolução 196/96 1996Search in Google Scholar

8 Conway DL, O Gonzales, D Skiver: Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J Matern Fetal Neonatal Med15 (2004) 51Search in Google Scholar

9 Coustan DR, RL Berkowitz, JC Hobbins: Tight metabolic control of overset diabetes in pregnancy. Am J Med68 (1980) 845Search in Google Scholar

10 Coustan DR, SB Lewis: Insulin therapy for gestational diabetes. Obstet Gynecol51 (1978) 306Search in Google Scholar

11 Daponte A, F Guidozzi, D Moisue, A Marineanu: Management of diabetic pregnant patients in a tertiary center in the developing world. Gynecol Obstet64 (1999) 141Search in Google Scholar

12 Fines V, T Moore, S Castle: A comparison of glyburide and insulin treatment in gestational diabetes mellitus on infant birth weight and adiposity. Am J Obstet Gynecol189 (2003) 108Search in Google Scholar

13 Garcia-Bournissen F, DS Feig, G Koren: Maternal-fetal transport of hipoglycaemic drug. Clin Pharmacokinet42 (2003) 303Search in Google Scholar

14 Hellmuth E, P Damm, L Molsted-Pedersen: Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med17 (2000) 507Search in Google Scholar

15 Honko CJ, EA Reece: Ambulatory care of the pregnant woman with diabetes. Clin Obstet Gynecol41 (1998) 584Search in Google Scholar

16 Jacobson JD, L Cousins: A population-based study of maternal and perinatal outcome in patients with gestational diabetes. Am J Obstet Gynecol161 (1989) 981Search in Google Scholar

17 Jovanovic L: American diabetes association's fourth international workshop-conference on gestational diabetes mellitus: summary and discussion. Diabetes Care21 (1998) 131Search in Google Scholar

18 Jovanovic L, DJ Pettin: Diabetes mellitus gestacional. JAMA Brasil7 (2003) 1446Search in Google Scholar

19 Kremer CJ, P Duff: Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol190 (2004) 175Search in Google Scholar

20 Landon MB, SG Gabbe: Diabete mélito. In: Barron WM, Lindhemeir MD (eds): Complicações médicas na gravidez. Artes Médicas, Porto Alegre 1996Search in Google Scholar

21 Langer O: Oral hypoglycemic agents and pregnant diabetic: from bench to bedside. Semin in Perinatol26 (2002) 21510.1053/sper.2002.33960Search in Google Scholar PubMed

22 Langer O, DL Conway, MD Berkus, EMJ Xenakis, ORN Gonzales: A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med343 (2000) 1134Search in Google Scholar

23 Larimore WL, KA Petrie: Drugs use during pregnancy and lactation. Primary Care: Clinics in Office Practice27 (2000) 49Search in Google Scholar

24 Ministério da Saúde: Diabetes gestacional. In: Manual de hipertensão arterial e diabetes mellitus (ed). Editora MS, Brasília 2002Search in Google Scholar

25 Ministério da Saúde: Secretaria de políticas de saúde In: Gestação de alto risco (eds) SPS, Brasília 2000Search in Google Scholar

26 Montenegro Jr RM, GMFG Paccola, CMFAPM Sales, APDR Montenegro, SM Jorge, G Duarte, MC Foss: Evolução materno-fetal de gestantes diabéticas seguidas no HC-FMRP-USP no período de 1992-1999. Arq Bras Endocrinol Oct45 (2001) 467Search in Google Scholar

27 MS/SVS/DASIS – Sistema de informações sobre nascimento – SINASC [online]. [citado em 5 Dez 2003]. Disponível em: http://www.datasus.gov.brSearch in Google Scholar

28 Oppermann MLR, AJ Reichelt: Diabete mélito e gestação. In: Freitas F, Martins-costa SH, Ramos JGL, Magalhães JÁ (eds): Rotinas em obstetrícia. Artmed, Porto Alegre 2001Search in Google Scholar

29 Platt J, W O'Brien: Acarbose therapy for gestational diabetes: a retrospective cohort study. Am J Obstet Gynecol189 (2003) 107Search in Google Scholar

30 Reece EA, C Honko, M Miodovnik, O Langer: A consensus report of the diabetes in pregnancy study group of north america conference. J Matern Fetal Neonatal Med12 (2002) 362Search in Google Scholar

31 Silva JC: Gestante diabética. EPUB, Rio de Janeiro 2003Search in Google Scholar

32 Zárate A, R Ochoa, M Herández, L Basurto: Eficacia de la acarbose para controlar el deterioro de la tolerancia a la glucosa durante la gestación. Ginecol Obstet Mex68 (2000) 42Search in Google Scholar

Published Online: 2005-12-01
Published in Print: 2005-12-01

©2005 by Walter de Gruyter Berlin New York

Downloaded on 23.4.2024 from https://www.degruyter.com/document/doi/10.1515/JPM.2005.092/html
Scroll to top button